These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1439871)

  • 1. Neuropsychiatric disorders: investigation of schizophrenia and substance abuse.
    Volkow ND; Fowler JS
    Semin Nucl Med; 1992 Oct; 22(4):254-67. PubMed ID: 1439871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroreceptor mapping with in-vivo imaging techniques: principles and applications.
    Busatto GF; Pilowsky LS
    Br J Hosp Med; 1995 Apr 5-18; 53(7):309-13. PubMed ID: 7788065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of positron emission tomography in psychiatry.
    Parsey RV; Mann JJ
    Semin Nucl Med; 2003 Apr; 33(2):129-35. PubMed ID: 12756645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional cerebral blood flow imaging with SPECT in psychiatric disease: focus on schizophrenia, anxiety disorders, and substance abuse.
    Woods SW
    J Clin Psychiatry; 1992 Nov; 53 Suppl():20-5. PubMed ID: 1459979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography in psychiatric and neuropsychiatric disorders.
    Dolan RJ; Friston KJ
    Semin Neurol; 1989 Dec; 9(4):330-7. PubMed ID: 2701777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders.
    Shen LH; Liao MH; Tseng YC
    J Biomed Biotechnol; 2012; 2012():259349. PubMed ID: 22570524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of regional cerebral function with FDG-PET imaging in neuropsychiatric disorders.
    Newberg A; Alavi A; Reivich M
    Semin Nucl Med; 2002 Jan; 32(1):13-34. PubMed ID: 11839066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography as a research tool in the investigation of psychiatric and psychological disorders.
    Jones AK; Friston K; Dolan R
    Baillieres Clin Endocrinol Metab; 1991 Mar; 5(1):187-203. PubMed ID: 1645517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical impact of cerebral dopamine-D2 receptor scintigraphy].
    Larisch R; Klimke A
    Nuklearmedizin; 1998; 37(7):245-50. PubMed ID: 9830615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET and SPECT in drug and substance abuse.
    Mena JC; Cuellar H; Vargas D; Riascos R
    Top Magn Reson Imaging; 2005 Jun; 16(3):253-6. PubMed ID: 16340650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of positron-emission tomography in psychiatry].
    Vlad T; Stanciu J
    Rev Med Chir Soc Med Nat Iasi; 1990; 94(1):95-7. PubMed ID: 1981625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of positron emission tomography in psychiatry].
    Degrell I; Berecz R; Glaub T; Lengyel Z; Egerházi A; Szakáll S; Trón L
    Orv Hetil; 2002 May; 143(21 Suppl 3):1311-4. PubMed ID: 12077925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron-emission tomography in neuropsychiatric disorders.
    Wegener WA; Alavi A
    Curr Opin Radiol; 1989 Dec; 1(4):475-84. PubMed ID: 2701383
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands.
    Kegeles LS; Mann JJ
    Neuropsychopharmacology; 1997 Nov; 17(5):293-307. PubMed ID: 9348545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography in psychiatry.
    Wiesel FA
    Psychiatr Dev; 1989; 7(1):19-47. PubMed ID: 2529539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography in neuropsychiatry.
    Faulstich ME; Sullivan DC
    Invest Radiol; 1991 Feb; 26(2):184-94. PubMed ID: 2055721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional imaging in mental disorders].
    Borbély K
    Orv Hetil; 2004 Feb; 145(6):277-89. PubMed ID: 15038321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioligands for brain 5-HT2 receptor imaging in vivo: why do we need them?
    Busatto GF
    Eur J Nucl Med; 1996 Aug; 23(8):867-70. PubMed ID: 8753673
    [No Abstract]   [Full Text] [Related]  

  • 19. PET imaging studies in drug abuse.
    Fowler JS; Volkow ND
    J Toxicol Clin Toxicol; 1998; 36(3):163-74. PubMed ID: 9656971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography and single-photon emission computed tomography in substance abuse research.
    Volkow ND; Fowler JS; Wang GJ
    Semin Nucl Med; 2003 Apr; 33(2):114-28. PubMed ID: 12756644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.